Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features - A clinicopathological study on 272 patients

Histology and Histopathology

Volumn 18, Issue 1, 2003, Pages 93-102

  Thiele, Juergen ^a   Kvasnicka, H M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow biopsies; Discriminate analysis; Essential thrombocythaemia; Fibres; Megakaryopoiesis

Indexed keywords

RETICULIN;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE FINDING; CELL NUCLEUS; CELL PROLIFERATION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EVALUATION; FEMALE; FIBER; FOLLOW UP; GIANT CELL; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MORPHOLOGY; MYELOFIBROSIS; PATHOLOGY; POLYCYTHEMIA VERA; PREDICTION; QUANTITATIVE ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; SURVIVAL; THROMBOCYTHEMIA; THROMBOCYTOSIS; VALIDATION PROCESS;

BONE MARROW CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOCYTOSIS;

EID: 0037217212     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Annaloro C., Lambertenghi Deliliers G., Oriani A., Pozzoli E., Lambertenghi Deliliers D., Radaelli F. and Faccini P. (1999) Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica 84, 17-21.
2. Bartl R., Frisch B. and Wilmanns W. (1993) Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol. 50, 41-52.
3. Bauermeister D.E. (1971) Quantitation of bone marrow reticulin - A normal range. Am. J. Clin. Pathol. 56, 24-31.
4. Bellucci S., Janvier M., Tobelem, G., Flandrin G., Charpak Y., Berger R. and Boiron M. (1986) Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 58, 2440-2447.
5. Buhr T., Georgiii A., Schuppan O., Amor A. and Kaloutsi V. (1992) Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann. Hematol. 64, 286-291.
6. Chistolini A., Mazzucconi M.G., Ferrari A., La Verde G., Ferrazza G., Dragoni F., Vitale A., Arcieri R. and Mandelli F. (1990) Essential thrombocythemia: A retrospective study on the clinical course of 100 patients. Haematologica 75, 537-540.
7. Colombi M., Radaelli F., Zocchi L. and Maiolo A.T. (1991) Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients. Cancer 67, 2926-2930.
8. Dudley J.M., Messinezy M., Eridani S., Holland L.J., Lawrie A., Nunan T.O., Sawyer B.,Savidge G.F. and Pearson T.C. (1989) Primary thrombocythaemia: Diagnostic criteria and a simple scoring system for positive diagnosis. Br. J. Haematol. 71, 331-335.
9. Everitt B.S. and Dunn G. (2001). Applied Multivariate Data Analysis. 2nd edn. Arnold. London.
10. Florensa L., Besses C., Woessner S., Sole F., Acin P., Pedro C. and Sans-Sabrafen J. (1995) Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. Leukemia 9, 271-273.
11. Georgii A, Vykoupil K.F., Buhr T., Choritz H., Dohleer U., Kaloutsi V. and Werner M. (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathol. Res. Pract. 186, 3-27.
12. Georgii A., Buesche G. and Kreft A. (1998) The histopathology of chronic myeloproliferative diseases. Baillieres Clin. Haematol. 11, 72-749.
13. Hakama M. and Hakulinen T. (1977) Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J. Chronic. Dis. 30, 585-597.
14. Hakulinen T. (1982) Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38, 933-942.
15. Hehlmann R., Jahn M., Baumann B., and Koepcke W. (1988) Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 61, 2487-2496.
16. Iland H.J., Laszlo J., Peterson P., Murphy S., Briere J., Weinfeld A., Rosenthal D.S., Landaw S.A., Ellis J.T., Silverstein M.N. and Wasserman L.R. (1983) Essential thrombocythemia: Clinical and laboratory characteristics at presentation. Trans. Assoc. Am. Physicians. 96, 165-174.
17. Imbert M., Pierre R., Thiele J., Vardiman J.W., Brunning R.D. and Fandrin G. (2001) Essential thrombocythaemia. In: WHO classification of tumours: Tumours of haematopoietic and lymphoid tissues. Jaffe E.S., Harris N.L., Stein H. and Vardiman J.W. (eds) IARC Press. Lyon. pp 39-41.
18. Jantunen R., Juvonen E., Ikkala E., Oksanen K., Anttila P., Hormila P., Jansson S.E., Kekomaki R. and Ruutu T. (1998). Essential thrombocythemia at diagnosis: Causes of diagnostic evaluation and presence of positive diagnostic findings. Ann. Hematol. 77, 101-106.
19. Juvonen E., Ikkala E., Oksanen K. and Ruutu T. (1993). Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications. Br. J. Haematol. 83, 192-197.
20. Kaloutsi V., Fritsch R.S., Buhr T., Restrepo-Specht I., Widjaja W. and Georgii A. (1991). Megakaryocytes in chronic myeloproliferative disorders: Numerical density correlated between different entities. Virchows Arch. (A) 418, 493-497.
21. Kvasnicka H.M., Thiele J., Werden C., Zankovich R., Diehl V. and Fischer R. (1997). Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 80, 708-719.
22. Lengfelder E., Hochhaus A., Kronawitter U., Hoche D., Queisser W., Jahn-Eder M., Burkhardt R., Reiter A., Ansari H. and Hehlmann R. (1998). Should a platelet limit of 600 × 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br. J. Haematol. 100, 15-23.
23. Mesa R.A., Silverstein M.N., Jacobsen S.J., Wollan P.C. and Tefferi A. (1999). Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County Study, 1976-1995. Am. J. Hematol. 61, 10-15.
24. Michiels J.J. and Juvonen E. (1997). Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin. Thromb. Hemost. 23, 339-347.
25. Murphy S., Peterson P., Iland H. and Laszlo J. (1997). Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin. Hematol. 34, 29-39.
26. Nafe R., Georgii A., Kaloutsi V., Fritsch R.S. and Choritz H. (1991). Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Arch. (B) 61, 111-116.
27. Rozman C., Giralt M., Feliu E., Rubio D. and Cortes M.T. (1991). Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 67, 2658-2663.
28. 9/L. Gruppo Italiano Malattie Mieloproliferative Croniche (GIMMC). Haematologica 85, 492-495.
29. Tefferi A., Silverstein M.N. and Hoagland H.C. (1995). Primary thrombocythemia. Semin. Oncol. 22, 334-340.
30. Thiele J., Schneider G., Hoeppner B., Wienhold S., Zankovich R. and Fischer R. (1988). Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - Features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows Arch. (A) 413, 407-417.
31. Thiele J., Kvasnicka H.M., Diehl V., Fischer R. and Michiels J. (1999a). Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk. Lymphoma 33, 207-218.
32. Thiele J., Kvasnicka H.M. and Fischer R. (1999b). Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - Aids to diagnosis and classification. Ann. Hematol. 78, 495-506.
33. Thiele J., Kvasnicka H.M., Zankovich R. and Diehl V. (2000). Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica 1126-1134.
34. Thiele J., Kvasnicka H.M., Zankovich R. and Diehl V. (2002). Early-stage idiopathic (primary) myelofibrosis - Current issues of diagnostic features. Leuk. Lymphoma 43, 1035-1141.
35. Van De Pette J.E., Prochazka A.V., Pearson T.C., Singh A.K., Dickson E.R. and Wetherley-Mein G. (1986). Primary thrombocythaemia treated with busulphan. Br. J. Haematol. 62, 229-237.
36. Van Genderen P.J. and Michiels J.J. (1993). Primary thrombocythemia: Diagnosis, clinical manifestations and management. Ann. Hematol. 67, 57-62.
37. Westwood N.B. and Pearson T.C. (1996). Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk. Lymphoma 22 (Suppl 1), 95-103.